Qameleon Therapeutics is rated 3 out of 5 in the category biotechnology. Read and write reviews about Qameleon Therapeutics. Qameleon Therapeutics is a spin off of the Netherlands Cancer Institute established in 2015 to accelerate finding drug combinations that overcome initial or acquired resistance to targeted therapy in oncology. Bringing new drug combinations affordably to patients
Company size
1-10 employees